drugset / Trial / NCT05221593

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

NCT05221593

Phase 3 Completed 50 enrolled Al-Azhar University
RandomizedParallel-groupOpen-labelPrevention

Summary

Using Lithium Carbonate to decrease incidence of neutropenia caused by using chemotherapy regimen in breast cancer patients.

Timeline

Start
2020-08-01
Primary completion
2022-04-01
Completion
2022-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Lithium Carbonate Unknown 400 mg

Indications